These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 37462520

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era.
    Condliffe R, Kiely DG, Peacock AJ, Corris PA, Gibbs JS, Vrapi F, Das C, Elliot CA, Johnson M, DeSoyza J, Torpy C, Goldsmith K, Hodgkins D, Hughes RJ, Pepke-Zaba J, Coghlan JG.
    Am J Respir Crit Care Med; 2009 Jan 15; 179(2):151-7. PubMed ID: 18931333
    [Abstract] [Full Text] [Related]

  • 4. Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial.
    Coghlan JG, Galiè N, Barberà JA, Frost AE, Ghofrani HA, Hoeper MM, Kuwana M, McLaughlin VV, Peacock AJ, Simonneau G, Vachiéry JL, Blair C, Gillies H, Miller KL, Harris JHN, Langley J, Rubin LJ, AMBITION investigators.
    Ann Rheum Dis; 2017 Jul 15; 76(7):1219-1227. PubMed ID: 28039187
    [Abstract] [Full Text] [Related]

  • 5. Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data.
    Thoreau B, Mouthon L.
    Autoimmun Rev; 2024 Apr 15; 23(4):103506. PubMed ID: 38135175
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pulmonary hypertension in connective tissue diseases: What every CTD specialist should know - but is afraid to ask!
    Sanges S, Sobanski V, Lamblin N, Hachulla E, Savale L, Montani D, Launay D.
    Rev Med Interne; 2024 Jan 15; 45(1):26-40. PubMed ID: 37925256
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype.
    Chung L, Liu J, Parsons L, Hassoun PM, McGoon M, Badesch DB, Miller DP, Nicolls MR, Zamanian RT.
    Chest; 2010 Dec 15; 138(6):1383-94. PubMed ID: 20507945
    [Abstract] [Full Text] [Related]

  • 11. Pulmonary arterial hypertension in connective tissue diseases.
    Goldberg A.
    Cardiol Rev; 2010 Dec 15; 18(2):85-8. PubMed ID: 20160534
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunosuppressive therapy in patients with connective tissue disease-associated pulmonary arterial hypertension: A systematic review.
    Ding Y, Qian J, Zhang S, Xu D, Leng X, Zhao J, Wang Q, Zhang W, Tian X, Li M, Zeng X.
    Int J Rheum Dis; 2022 Sep 15; 25(9):982-990. PubMed ID: 35699128
    [Abstract] [Full Text] [Related]

  • 14. Pulmonary arterial hypertension related to connective tissue disease: a review.
    Ahmed S, Palevsky HI.
    Rheum Dis Clin North Am; 2014 Feb 15; 40(1):103-24. PubMed ID: 24268012
    [Abstract] [Full Text] [Related]

  • 15. Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions.
    Denton CP, Humbert M, Rubin L, Black CM.
    Ann Rheum Dis; 2006 Oct 15; 65(10):1336-40. PubMed ID: 16793845
    [Abstract] [Full Text] [Related]

  • 16. Real-World Treatment Patterns Among Patients with Connective Tissue Disorder-Related Pulmonary Arterial Hypertension in the United States: A Retrospective Claims-Based Analysis.
    Sargent T, Tsang Y, Panjabi S, Funtanilla V, Germack HD, Gauthier-Loiselle M, Manceur AM, Cloutier M, Lefebvre P.
    Adv Ther; 2023 Nov 15; 40(11):5037-5054. PubMed ID: 37728697
    [Abstract] [Full Text] [Related]

  • 17. Epidemiology and mortality of connective tissue disease-associated pulmonary arterial hypertension: A national cohort study in taiwan.
    Lin CY, Ko CH, Hsu CY, Chen HA.
    Semin Arthritis Rheum; 2020 Oct 15; 50(5):957-962. PubMed ID: 32906031
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: A cohort study in China.
    Zhao J, Wang Q, Liu Y, Tian Z, Guo X, Wang H, Lai J, Huang C, Yang X, Li M, Zeng X.
    Int J Cardiol; 2017 Jun 01; 236():432-437. PubMed ID: 28159359
    [Abstract] [Full Text] [Related]

  • 20. [Pulmonary arterial hypertension associated with connective tissue diseases].
    Legendre P, Mouthon L.
    Presse Med; 2014 Sep 01; 43(9):957-69. PubMed ID: 25129118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.